133 related articles for article (PubMed ID: 12711645)
1. Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance programme for the START trial in early breast cancer.
Winfield EA; Deighton A; Venables K; Hoskin PJ; Aird EG;
Br J Radiol; 2003 Apr; 76(904):254-9. PubMed ID: 12711645
[TBL] [Abstract][Full Text] [Related]
2. Survey of UK breast radiotherapy techniques: background prior to the introduction of the quality assurance programme for the START (standardisation of radiotherapy) trial in breast cancer.
Winfield E; Deighton A; Venables K; Hoskin PJ; Aird EG
Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):267-71. PubMed ID: 12206636
[TBL] [Abstract][Full Text] [Related]
3. Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial.
Tsang Y; Venables K; Yarnold J;
Br J Radiol; 2012 Sep; 85(1017):e647-53. PubMed ID: 22294704
[TBL] [Abstract][Full Text] [Related]
4. The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial.
Venables K; Miles EA; Aird EG; Hoskin PJ;
Radiother Oncol; 2004 Jun; 71(3):303-10. PubMed ID: 15172146
[TBL] [Abstract][Full Text] [Related]
5. Dosimetry and field matching for radiotherapy to the breast and supraclavicular fossa.
Miles EA; Venables K; Hoskin PJ; Aird EG;
Radiother Oncol; 2009 Apr; 91(1):42-8. PubMed ID: 19195731
[TBL] [Abstract][Full Text] [Related]
6. Breast radiotherapy phantom design for the START trial. START trial management group.
Venables K; Winfield E; Deighton A; Aird E; Hoskin P;
Br J Radiol; 2000 Dec; 73(876):1313-6. PubMed ID: 11205676
[TBL] [Abstract][Full Text] [Related]
7. Direct aperture optimization of breast IMRT and the dosimetric impact of respiration motion.
Zhang G; Jiang Z; Shepard D; Zhang B; Yu C
Phys Med Biol; 2006 Oct; 51(20):N357-69. PubMed ID: 17019024
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy.
Wills L; Maggs R; Lewis G; Jones G; Nixon L; Staffurth J; Crosby T;
Radiat Oncol; 2017 Nov; 12(1):179. PubMed ID: 29141663
[TBL] [Abstract][Full Text] [Related]
9. Automatic generation of a plan optimization volume for tangential field breast cancer radiation therapy.
Van Vaerenbergh K; De Gersem W; Vakaet L; Coghe M; Boterberg T; Bakker M; Derie C; Willaert W; Seij P; Duthoy W; De Wagter C; De Neve W
Strahlenther Onkol; 2005 Feb; 181(2):82-8. PubMed ID: 15702296
[TBL] [Abstract][Full Text] [Related]
10. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
11. What is the optimum breast plan: a study based on the START trial plans.
Venables K; Miles EA; Aird EG; Hoskin PJ
Br J Radiol; 2006 Sep; 79(945):734-9. PubMed ID: 16940374
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.
Tsang Y; Ciurlionis L; Kirby AM; Locke I; Venables K; Yarnold JR; Titley J; Bliss J; Coles CE;
Br J Radiol; 2015; 88(1056):20150453. PubMed ID: 26492402
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive clinical 3-dimensional dosimetric analysis of forward planned IMRT and conventional wedge planned techniques for intact breast radiotherapy.
Herrick JS; Neill CJ; Rosser PF
Med Dosim; 2008; 33(1):62-70. PubMed ID: 18262125
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric analysis of intact breast irradiation in off-axis planes.
Buchholz TA; Gurgoze E; Bice WS; Prestidge BR
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):261-7. PubMed ID: 9300762
[TBL] [Abstract][Full Text] [Related]
15. Multicentre quality assurance of intensity-modulated radiation therapy plans: a precursor to clinical trials.
Williams MJ; Bailey M; Forstner D; Metcalfe PE
Australas Radiol; 2007 Oct; 51(5):472-9. PubMed ID: 17803801
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of HDR interstitial breast implants planned by conventional and optimized CT-based dosimetry systems with respect to dose homogeneity and conformality.
Major T; Fodor J; Takácsi-Nagy Z; Agoston P; Polgár C
Strahlenther Onkol; 2005 Feb; 181(2):89-96. PubMed ID: 15702297
[TBL] [Abstract][Full Text] [Related]
17. Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer.
Clark CH; Miles EA; Urbano MT; Bhide SA; Bidmead AM; Harrington KJ; Nutting CM;
Br J Radiol; 2009 Jul; 82(979):585-94. PubMed ID: 19332518
[TBL] [Abstract][Full Text] [Related]
18. Peer Review of Radiotherapy Planning: Quantifying Outcomes and a Proposal for Prospective Data Collection.
Mackenzie J; Graham G; Olivotto IA
Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e192-e198. PubMed ID: 27633327
[TBL] [Abstract][Full Text] [Related]
19. Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works.
Poortmans P; Kouloulias V; van Tienhoven G; Collette L; Struikmans H; Venselaar JL; Van den Bogaert W; Davis JB; Lambin P;
Strahlenther Onkol; 2006 Oct; 182(10):576-82. PubMed ID: 17013570
[TBL] [Abstract][Full Text] [Related]
20. A methodology for verification of radiotherapy dose calculation.
Agazaryan N; Ullrich W; Lee SP; Solberg TD
J Neurosurg; 2004 Nov; 101 Suppl 3():356-61. PubMed ID: 15537190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
